We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Psychedelics – News and Features

News

Aspire IRB, Independent Review Board is Breaking new Ground Overseeing Clinical Research Trials

The Company has announced record growth, new medical director and pediatric board member.
News

MicroDose Technologies Announces Achievement of Phase I Clinical Milestone under Collaboration with Merck

The milestone signals the initiation by Merck of a Phase I clinical study of an investigational compound using the MicroDose DPI technology.
News

New Data Further Strengthens Case for Microdosing in Drug Development

The EUMAPP consortium presented preliminary results from the 30-month, €2m project at the EUFEPS Conference.
News

Scientists in Spain Develop New Methods for Monitoring Drug Abuse by Analyzing Wastewater

Applied Biosystems/MDS Analytical Technologies technology helps provide new insights into consumption of illegal drugs.
News

Dymension 2D Gel Analysis Software used at Specialist Institute

Syngene’s software is being used to identify proteins induced by an anti-addictive compound.
News

Vitalea Science Partners with SGS Life Science Services to Provide Microdosing Studies

The partnership further strengthens the complementary services offered by both SGS and Vitalea in executing early clinical trials based on the exploratory-IND concept.
News

Xceleron and Organon Sign Microdose Study Agreement

Xceleron announce collaboration with Organon on a three-compound human microdose study focusing on candidate selection for further clinical development.
News

Corcept Therapeutics and Xceleron Sign Agreement for Microdosing Study Using Accelerator Mass Spectrometry

The agreement aims at a human microdosing study of one of Corcept’s new chemical entities utilizing Xceleron’s AMS technology.
News

Vitalea Science Completes Dermal Distribution Microdose Study

Vitalea has completed a microdosing study assessing properties of a nutrient compound essential to prostate health and prevention of cellular oxidative damage.
News

Sensitive Pediatric Pharmacology Assays for HIV Drugs Developed by Vitalea Science

Vitalea recieves NIAID grant to develop and test assays that can be applied to children and neonates to quantify intracellular uptake of antiretroviral drugs.
Advertisement